Chronic pancreatitis mass is a focal inflammatory-fibrotic mass developing on the background of chronic pancreatitis, and its differentiation from ductal adenocarcinoma is one of the most challenging diagnostic problems in radiology. Focal enlargement accompanied by chronic inflammation, fibrosis, and calcifications typically occurs in the pancreatic head. Long-term alcohol use or recurrent pancreatitis attacks are the most common etiological factors. Parenchymal calcifications, main duct dilatation, and 'chain of lakes' pattern confirm the chronic pancreatitis background, but the 5-10% risk of concurrent adenocarcinoma development requires careful evaluation.
Age Range
40-70
Peak Age
55
Gender
Male predominant
Prevalence
Uncommon
Chronic pancreatitis is a process where recurrent inflammatory damage leads to progressive fibrosis, acinar cell loss, and ductal changes in the pancreatic parenchyma. Focal mass formation results from intensification of fibrosis and inflammatory infiltration in a localized area. Fibrotic tissue shows vascular kinetics similar to the desmoplastic stroma of adenocarcinoma — hypovascularity on arterial phase and delayed enhancement. Parenchymal calcifications form when protein plugs within ducts calcify during the recurrent necrosis-healing cycle. These calcified plugs cause duct obstruction, upstream dilatation, and the 'chain of lakes' pattern. The 5-10% risk of adenocarcinoma development on chronic pancreatitis background makes tumor detection within fibrotic tissue extremely difficult, as both conditions show similar imaging characteristics.
Alternation of irregular dilatation and narrowing segments of the main pancreatic duct, creating a 'chain of interconnected lakes' appearance. This pattern is pathognomonic for chronic pancreatitis and results from irregular strictures of the duct wall due to recurrent inflammation and fibrosis. Best evaluated on T2-weighted sequences and MRCP. Intraductal calcified plugs cause segmental narrowings, with compensatory dilatation in segments between strictures.
Multiple punctate or coarse calcifications are seen in the pancreatic parenchyma and within the duct on unenhanced CT. These calcifications are definitive evidence of chronic pancreatitis. Calcifications may be more dense in the focal mass area.
Report Sentence
Multiple punctate and coarse calcifications are seen in the pancreatic parenchyma, consistent with chronic pancreatitis.
On arterial phase, a focal hypoattenuating mass is seen on the background of chronic pancreatitis. It enhances significantly less than normal parenchyma. Mass borders are diffuse and gradual; calcifications may be seen within the mass.
Report Sentence
A focal hypoattenuating mass is seen in the pancreatic head on arterial phase with chronic pancreatitis features; adenocarcinoma should be excluded in the differential diagnosis.
On delayed phase, the fibrotic mass shows progressive enhancement. The contrast difference with normal parenchyma decreases and may even become isodense to mildly hyperdense. This delayed enhancement pattern indicates fibrosis dominance.
Report Sentence
The focal mass demonstrates progressive enhancement on delayed phase, which may favor a fibrotic process.
On T2-weighted sequences, the focal mass appears heterogeneously hypointense. Fibrotic tissue shows low signal while edema or small cystic areas may create hyperintense foci. The focal mass may be more conspicuous against the background of diffuse T2 hypointensity of chronic pancreatitis.
Report Sentence
The focal mass appears heterogeneously hypointense on T2-weighted sequences, suggesting coexistence of fibrosis and inflammatory areas.
Variable degrees of diffusion restriction may be seen in the focal mass on DWI. Fibrotic areas show moderate restriction while active inflammatory areas may demonstrate more pronounced restriction. ADC values can overlap with adenocarcinoma.
Report Sentence
Variable diffusion restriction is seen in the focal mass on DWI with ADC values not providing definitive differentiation.
On B-mode ultrasonography, a focal hypoechoic mass is seen against the background of chronic pancreatitis. Diffuse increased echogenicity of parenchyma (fibrosis), punctate hyperechoic foci (calcifications), and dilated main duct accompany. Coarse calcifications with shadowing may be detected.
Report Sentence
A focal hypoechoic mass is seen in the pancreatic head with chronic pancreatitis features (calcifications, duct dilatation); advanced imaging is recommended to exclude adenocarcinoma.
Criteria
Focal mass with prominent parenchymal and intraductal calcifications, alcohol etiology predominant, long disease duration (>5 years)
Distinct Features
Dense calcifications are seen within the mass on CT. Calcifications may extend beyond the mass borders involving the entire parenchyma. The main duct may be dilated and filled with calcified stones. Intraductal calcification is rare in adenocarcinoma — this finding is strong evidence favoring chronic pancreatitis.
Criteria
Focal mass in the pancreatic head with obstruction of CBD and main pancreatic duct ('double duct sign'), jaundice may accompany
Distinct Features
Double duct sign increases adenocarcinoma suspicion but can also be seen in chronic pancreatitis mass. In chronic pancreatitis mass, CBD narrowing is usually smooth-contoured and long-segment (abrupt and short-segment in adenocarcinoma). Duct wall irregularity and mural nodularity are findings favoring adenocarcinoma. EUS-FNA is most frequently indicated in this subtype.
Criteria
Newly developing or rapidly growing focal mass in a patient with known chronic pancreatitis, elevated CA 19-9, unexplained weight loss
Distinct Features
Adenocarcinoma risk is 10-20 fold increased in chronic pancreatitis patients compared to the general population. New vascular invasion, rapid size increase, newly developing distant metastasis, or CA 19-9 elevation should raise suspicion. PET-CT may help differentiate adenocarcinoma from chronic pancreatitis mass (high FDG uptake in adenocarcinoma) but false positives can occur in active inflammation.
Distinguishing Feature
Adenocarcinoma shows vascular invasion (SMA/SMV encasement), abrupt duct cutoff, regional LAP, and distant metastasis. In chronic pancreatitis mass, duct-penetrating sign (duct traceable through mass), smooth-contoured CBD narrowing, parenchymal calcifications, and absence of vascular invasion are distinguishing. CA 19-9 >200 U/mL strongly favors adenocarcinoma.
Distinguishing Feature
In AIP, capsule-like rim, diffuse sausage-shaped enlargement, IgG4 elevation, and steroid response are distinguishing. In chronic pancreatitis mass, calcifications, chain of lakes pattern, and long disease history are expected. Calcifications are rare in AIP.
Distinguishing Feature
Groove pancreatitis is localized to the groove region between pancreatic head and duodenum with duodenal wall cystic changes. Chronic pancreatitis mass is within the pancreatic parenchyma with accompanying diffuse calcifications.
Distinguishing Feature
Parenchymal calcifications and duct dilatation are not expected in lymphoma. Lymphoma is typically a large homogeneous hypoattenuating mass that encases vessels without invasion. In chronic pancreatitis mass, calcifications and chain of lakes pattern support the diagnosis.
Urgency
urgentManagement
surgicalBiopsy
NeededFollow-up
3-monthDifferentiation between chronic pancreatitis mass and adenocarcinoma is one of the most challenging diagnostic problems in clinical practice. EUS-FNA is the gold standard diagnostic method but sensitivity drops to 70-85% in the setting of chronic pancreatitis (desmoplastic stroma and fibrosis may cause sampling inadequacy). CA 19-9 >200 U/mL strongly favors adenocarcinoma but can also be elevated in cholangitis and obstructive jaundice. PET-CT may help differentiate adenocarcinoma (SUV >3.5) from chronic pancreatitis (SUV <3.0). If diagnostic uncertainty persists, surgical exploration (Whipple procedure) is recommended — the risk of missing adenocarcinoma in chronic pancreatitis background is unacceptable. Follow-up should be performed with CT/MRI every 3 months.
Mass-forming chronic pancreatitis is one of the most challenging entities to differentiate from PDAC. EUS-FNA is the gold standard for diagnosis but a negative result does not exclude malignancy. Surgical resection is often performed for both diagnostic and therapeutic purposes.